Fundraising Fox
Find your path to Mark
Sign up to see every warm intro you have to Mark
- Paths you didn't know you had: your email and LinkedIn already hold routes to Mark. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Venture Partner and veteran biopharma scientist and drug developer, known as primary inventor of linaclotide (Linzess) and former President/CSO and scientific founder of Cyclerion Therapeutics. Holds board and advisory roles across several biotech companies. Earned a PhD from Wake Forest School of Medicine.
Deals · 1
Sea PharmaceuticalsBoard seat
via Iaso Ventures · filed May 2026 · $1.7M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Iaso Ventures
Frequently asked questions
- Who is Mark G. Currie?
- Venture Partner and veteran biopharma scientist and drug developer, known as primary inventor of linaclotide (Linzess) and former President/CSO and scientific founder of Cyclerion Therapeutics. Holds board and advisory roles across several biotech companies. Earned a PhD from Wake Forest School of Medicine.
- Where does Mark G. Currie work?
- Mark G. Currie is Venture Partner at Iaso Ventures.
- What boards does Mark G. Currie sit on?
- Mark G. Currie holds tracked board seats at Sea Pharmaceuticals.
About this profile. Compiled from public sources — Iaso Ventures's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights